Recent Articles By The Author
The insider purchases were at an oil refiner, a video game maker and a retailer of recreational vehicles.
With all the unknowns surrounding Boeing it's way too early to take a position in the aircraft maker; the same is not true with CVS.
Economic reports out of Europe and China have not been encouraging, which appears to leave the U.S. to power the global economic engine.
Insider purchases have tapered off from their frenzied pace in late 2018, but here are three names where such buying is evident.
One big change over the last few years has been the struggle of small concerns to penetrate mass markets even with approved and superior drugs.
As Kenny Rogers sang, you've got to know when to hold 'em and know when to fold 'em… and sometimes when not to play a hand at all.
Small-caps have done better than their bigger brethren so far in 2019, and these three stocks are a reason why.
Quick takes on fourth-quarter results from these 3 biotech names.
Acquisition deals for biotech companies at the start of 2019 are giving the sector a nice boost; here are other names that could be merger candidates.